| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Departments of Medicine and Physiology, Harbor General Hospital Torrance, California
Evidence has been presented by others that βSMSH immunoreactivity in human plasma is due to β and
lipotropin rather than βMSH. We have studied this question in normal subjects utilizing a sensitive human /3MSH radioimmunoassay capable of quantifying βMSH in unextracted plasma with a sensitivity of 7.5 pg/ml. Purified human /3 lipotropin cross-reacted 30% on a molar basis with synthetic human βMSH in this assay. ACTH related peptides showed <0.1% cross-reactivity. Normal values at 0800 h were 19.6±2.4 pg/ml and suppressed to 9.3±1.3 pg/ml following dexamethasone. Metyrapone increased 0800 h values to 379.6±89.9 pg/ml. Chromatographic studies on Sephadex G-50 demonstrated no /3MSH per se in human pituitaries, plasma from metyrapone treated normals, patients with Cushing's disease, Nelson's syndrome, or Addison's disease. βMSH immunoreactivity showed the elution pattern of βlipotropin.
* Present address: Ivan Bachelot, M.D., C.H.U. de Grenoble, 38.700 La Tronche, France.
Supported by NCI Contract No. NOI-CB-43903. Dr. Bachelot was supported by the Council for Int'l Exch. of Persons (Sr. Fulbright-Hays Program Travel Grant
These studies were presented at the Western section of the American Federation for Clinical Research, Feb. 1976, Carmel, California.
Received August 9, 1977.
This article has been cited by other articles:
![]() |
E. M. GOLD The Cushing Syndromes: Changing Views of Diagnosis and Treatment Ann Intern Med, May 1, 1979; 90(5): 829 - 844. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |